|
Volumn 16, Issue 1, 2001, Pages 1-6
|
A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity
a a a a a a a a a a a a a |
Author keywords
CRaf1 kinase inhibition; Mitogen activated protein kinase; Phenol isostere; Phenol prodrug
|
Indexed keywords
ANTINEOPLASTIC AGENT;
C RAF1 KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
PHENOL;
PRODRUG;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CELL CULTURE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG DESIGN;
DRUG POTENCY;
ENZYME INHIBITION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
ANTINEOPLASTIC AGENTS;
CELLS, CULTURED;
DOWN-REGULATION;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
INDICATORS AND REAGENTS;
MITOGEN-ACTIVATED PROTEIN KINASES;
PHENOLS;
PRODRUGS;
PROTEINS;
PROTO-ONCOGENE PROTEINS C-RAF;
STRUCTURE-ACTIVITY RELATIONSHIP;
TNF RECEPTOR-ASSOCIATED FACTOR 3;
ANIMALIA;
|
EID: 0035196837
PISSN: 02669536
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (28)
|
References (18)
|